Back to Search
ASHA PATNAIK, MD
MD
Rheumatology Physician
NPI: 1386742419IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
5898(SD)35-090755(OH)
Hospitalist Physician
Hospitalist
Code: 208M00000X
35.090755(OH)
Rheumatology PhysicianPrimary
Internal Medicine — Rheumatology
Code: 207RR0500X
263442(NY)
CMS Specialties
PrimaryRHEUMATOLOGY
Education
OTHER
Class of 1990
Research & Publications (20)
Hepatobiliary neuroendocrine carcinoma in cats: a clinicopathologic, immunohistochemical, and ultrastructural study of 17 cases.
PMID 15872379·Vet Pathol·2005
4-observational
Canine hepatic neuroendocrine carcinoma: an immunohistochemical and electron microscopic study.
PMID 15753467·Vet Pathol·2005
7-preclinical
Feline cystic thymoma: a clinicopathologic, immunohistologic, and electron microscopic study of 14 cases.
PMID 12547620·J Feline Med Surg·2003
5-case
Malignant nerve-sheath tumor with divergent and glandular differentiation in a dog: a case report.
PMID 12014509·Vet Pathol·2002
5-case
Clinicopathologic and electron microscopic study of cutaneous neuroendocrine (Merkel cell) carcinoma in a cat with comparisons to human and canine tumors.
PMID 11572564·Vet Pathol·2001
5-case
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.
PMID 19633048·Ann Oncol·2010
3-trial
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
PMID 19449006·Cancer Chemother Pharmacol·2009
3-trial
Phase I and pharmacokinetic study of XRP6258 (RPR 116258A), a novel taxane, administered as a 1-hour infusion every 3 weeks in patients with advanced solid tumors.
PMID 19147780·Clin Cancer Res·2009
3-trial
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.
PMID 18795291·Cancer Chemother Pharmacol·2009
3-trial
Effects of collisions on electronic-resonance-enhanced coherent anti-Stokes Raman scattering of nitric oxide.
PMID 19508066·J Chem Phys·2009
8-other
Bioequivalence study of a new oral topotecan formulation, relative to the current topotecan formulation, in patients with advanced solid tumors.
PMID 19281729·Int J Clin Pharmacol Ther·2009
3-trial
Spatial distribution of orofacial cleft defect births in Harris County, Texas, and radium in the public water supplies: a persistent association?
PMID 19065472·Tex Med·2008
8-other
Unilamellar composite vesicles and Y-junctions from pristine fullerene C(60).
PMID 18802505·Chem Commun (Camb)·2008
8-other
Perturbative theory and modeling of electronic-resonance-enhanced coherent anti-Stokes Raman scattering spectroscopy of nitric oxide.
PMID 18465923·J Chem Phys·2008
8-other
Controlled parametric generation in a double-ladder system via all-resonant four-wave mixing.
PMID 18278117·Opt Lett·2008
8-other
Phase I pharmacokinetic and pharmacodynamic study of LAQ824, a hydroxamate histone deacetylase inhibitor with a heat shock protein-90 inhibitory profile, in patients with advanced solid tumors.
PMID 18927309·Clin Cancer Res·2008
3-trial
Phase I and pharmacokinetic study of YM155, a small-molecule inhibitor of survivin.
PMID 18824702·J Clin Oncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 26 RESEARCH WAY
EAST SETAUKET, NY 11733 - Phone
- (631) 444-0580
Quick Facts
- NPI
- 1386742419
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 4
- Locations
- 1
- Years in Practice
- 36
- Publications
- 20
Are you this provider?
Claim Your Profile